ESC 365 - Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England

ESC Premium Access

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England

Session: Best Posters 7 - Best Posters in prevention

Topic: Epidemiology, lipids

Speaker: Doctor P. Ueda (Stockholm, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Peter Ueda

Karolinska Institute, Stockholm (Sweden)

2 presentations

1 follower

4 more presentations in this session

Discussant: Best Posters in prevention

The long-term prognostic value of radiofrequency intravascular ultrasound for major adverse cardiovascular events in patients with coronary artery disease during 4.7-years follow-up.

Speaker: Miss A. Schuurman (Rotterdam, NL)

Physical exercise- mediated effects on left ventricular diastolic function outweigh other modifiable risk factors in coronary artery disease patients

Speaker: Doctor A. Boscheri (Munich, DE)

Beta-blocker dose is associated with mortality after myocardial infarction - a nationwide study

Speaker: Doctor S. Pedersen (Aarhus, DK)

Access the full session

Best Posters 7 - Best Posters in prevention

Speakers: Doctor P. Ueda, Miss A. Schuurman, Doctor A. Boscheri, Doctor S. Pedersen

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources